ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded Eligibility for Early Stage Breast
Veronica Shim1, Audrey Karlea2, Leslie Manace Brenman2
1Department of Surgery, Oakland, CA, USA. veronica.shim@kp.org.
Annals of Surgical Oncology
|December 5, 2024
Summary
No abstract available in PubMed .
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
